Evidence map›Paper›PMID 41498666›Full record

ArticleIndian journal of pharmacology2026

Drug-induced mania and parkinsonism in substance use disorder patient: A case report.

Ragesh Gurumoorthi, Ramakrishnan Subbaraya Rajendran, Akila Murugan, Karthik Thiyagarajan, Muhasaparur Ganesan Rajanandh

Abstract readCase Reports
In one paragraph

Article in Indian journal of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ragesh GurumoorthiDepartment of Pharmacy Practice, Chettinad School of Pharmaceutical Sciences, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India.
Ramakrishnan Subbaraya RajendranDepartment of General Medicine, Sri Ramachandra Medical College and Hospital, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
Akila MuruganDepartment of General Medicine, Sri Ramachandra Medical College and Hospital, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
Karthik ThiyagarajanDepartment of General Medicine, Sri Ramachandra Medical College and Hospital, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
Muhasaparur Ganesan RajanandhDepartment of Pharmacy Practice, SRM College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractThis case report investigates mania and parkinsonism induced by olanzapine and disulfiram in a patient with substance use disorder. DSM-5 criteria were used for the diagnosis of drug-induced parkinsonism, and movement disorder severity was assessed with the Simpson-Angus Scale. After initiating olanzapine and disulfiram therapy, the patient developed extrapyramidal symptoms and manic features. Naranjo scale indicated a probable drug reaction (score = 7), while Hartwig Severity Assessment (Level 4) suggested that hospitalization was required and these reactions were nonpreventable. The case underscores the need for vigilant monitoring and tailored treatment in patients with psychiatric conditions.

Indexed as

Antipsychotic AgentsBipolar DisorderManiaParkinson Disease, SecondarySubstance-Related DisordersBenzodiazepinesDisulfiramHumansOlanzapineAntipsychotic AgentsBenzodiazepinesDisulfiramOlanzapineAdverse effectsdisulfiramextra pyramidal symptoms and neurological disorderolanzapine

Identifiers

PMID41498666
PMCPMC12875521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.